{
  "nctId": "NCT03702465",
  "briefTitle": "Assessment of the Impact of a Personalised Nutrition Intervention in Impaired Glucose Regulation",
  "officialTitle": "Assessment of the Impact of a Personalised Nutrition Intervention in Impaired Glucose Regulation",
  "protocolDocument": {
    "nctId": "NCT03702465",
    "filename": "Prot_002.pdf",
    "label": "Study Protocol",
    "date": "2020-03-16",
    "uploadDate": "2020-10-01T11:04",
    "size": 554019,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03702465/document/Prot_002.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 180,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2018-11-26",
    "completionDate": "2022-11-30",
    "primaryCompletionDate": "2022-10-10",
    "firstSubmitDate": "2018-10-05",
    "firstPostDate": "2018-10-11"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Provision of signed and dated informed consent form\n* Adults over 18 years of age\n* Impaired glucose regulation including impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) by fasting glucose, oral glucose tolerance test (OGTT) or HbA1c criteria\n* Access to smart phone with an operating system of iOS 8.0 or above, or Android 4.0 or above.\n\nExclusion Criteria:\n\n* Diabetic\n* Pregnant or planning pregnancy\n* Breastfeeding\n* Enrolled in other clinical trials\n* Have active malignancy or under investigation for malignancy\n* Severe visual impairment\n* Reduced manual dexterity\n* Use of psychiatric, anti-diabetic, and/or weight loss medication, and/or oral steroids\n* Bariatric surgery\n* History of illnesses that could interfere with the interpretation of the study results (e.g. HIV, Cushing syndrome, chronic kidney disease, chronic liver disease, hyperthyroidism, hereditary fructose intolerance, alcohol or substance abuse)\n* Unable to participate due to other factors, as assessed by the Chief Investigator",
    "healthyVolunteers": true,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Difference in glucose regulation between the control and intervention arm",
        "description": "Difference in 0 minutes glucose on 75g oral glucose tolerance test between the control arm and the intervention arm.",
        "timeFrame": "6 weeks"
      }
    ],
    "secondary": [
      {
        "measure": "120 minutes glucose on 75g oral glucose tolerance test",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "0 minutes glucose on 75g oral glucose tolerance test",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Concentration of glycated haemoglobin in blood",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 12 and 26 weeks.",
        "timeFrame": "12 and 26 weeks"
      },
      {
        "measure": "Weight",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "BMI",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Lean mass",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Fat mass",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Waist circumference",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Measurement of total cholesterol in blood",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Measurement of fasting triglycerides in blood",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Measurement of LDL cholesterol in blood",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Measurement of HDL cholesterol in blood",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)",
        "description": "Derived from measurements of insulin and glucose in blood. Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Measurement of 120 minute c-peptide",
        "description": "Measured after a 75g oral glucose tolerance test. Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Systolic blood pressure",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Diastolic blood pressure",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6,12 and 26 weeks"
      },
      {
        "measure": "Dietary intake",
        "description": "Dietary intake will be assessed using 24-hours recall questionnaire (food frequency questionnaire \\[FFQ\\]) at visits 4, 5, 7, 9 and 11. Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6,12 and 26 weeks"
      },
      {
        "measure": "Energy intake from a food frequency questionnaire",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6,12 and 26 weeks"
      },
      {
        "measure": "Carbohydrate intake from a food frequency questionnaire",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Fat intake from a food frequency questionnaire",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Saturated fat intake from a food frequency questionnaire",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Salt intake from a food frequency questionnaire",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6,12 and 26 weeks"
      },
      {
        "measure": "Concentration of Vitamin D in blood",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Concentration of Vitamin B6 in blood",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Vitamin B12 from a food frequency questionnaire",
        "description": "Cross-arm and within arm differences (compared to 0 week measurements) between the control arm, intervention arm, and the exploratory arm, measured at 6, 12 and 26 weeks.",
        "timeFrame": "6, 12 and 26 weeks"
      },
      {
        "measure": "Number of participant withdrawals in the trial",
        "description": "Number of participant withdrawals in the trial",
        "timeFrame": "26 weeks"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 26,
      "otherCount": 0,
      "totalCount": 27
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 100,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:29:41.173Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}